Identification of novel combined biomarkers in the diagnosis of multiple myeloma-Reference-Cited by-同舟云学术

Identification of novel combined biomarkers in the diagnosis of multiple myeloma

Author:

Jin Yanxia¹²,Liang Yuxing¹,Su Yanting³,Hui Lingyun⁴,Liu Hailing⁵,Ding Lu¹,Zhou Fuling¹^ORCID

Affiliation:

1. Department of Haematology, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China

2. Hubei Key Laboratory of Edible Wild Plants Conservation and Utilization, Hubei Normal University, Huangshi, People’s Republic of China

3. College of Life Sciences, Wuhan University, Wuhan, People’s Republic of China

4. Department of Laboratory Medicine, First Affiliated Hospital, Medical School of Xi’an Jiaotong University, Xi’an, People’s Republic of China

5. Department of Clinical Haematology, Second Affiliated Hospital, Medical School of Xi’an Jiaotong University, Xi’an, People’s Republic of China

Funder

Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund Project

the Natural Science Foundation of China (NSFC) programme

the Natural Science Foundation of Hubei Province programme

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

Reference28 articles.